review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Amy C Y Lo | |
Angela Ka Wai Lai | |||
P2860 | cites work | Reduction of basement membrane thickening in diabetic cat retina by sulindac | Q68738839 |
Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio | Q69632257 | ||
Ocular pathology of diabetes mellitus | Q70099993 | ||
Flat-Mount Studies of Human Retinal Vessels⋆ | Q71169874 | ||
Localization of vascular endothelial growth factor in human retina and choroid | Q71226459 | ||
A mouse model of diabetic retinopathy | Q71226463 | ||
Pathologic studies of the blood--retinal barrier in the spontaneously diabetic BB rat | Q71275185 | ||
Oxygen-induced retinopathy in the mouse | Q71608431 | ||
The BB Wistar rat: an experimental model for the study of diabetic retinopathy | Q71773247 | ||
Diabetic retinopathy in a cat | Q71889695 | ||
Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization | Q72120451 | ||
Galactose-induced retinal microangiopathy in rats | Q72512545 | ||
Diabeteslike proliferative retinal changes in galactose-fed dogs | Q72624907 | ||
Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat | Q72650581 | ||
Diabetes, a New Mutation in the Mouse | Q72798788 | ||
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia | Q73127991 | ||
Acarbose partially inhibits microvascular retinopathy in the Zucker Diabetic Fatty rat (ZDF/Gmi-fa) | Q73279495 | ||
Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability | Q73347985 | ||
Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates | Q73519344 | ||
Electroretinogram in sucrose-fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant | Q73890660 | ||
Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats | Q74052511 | ||
Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice | Q74091486 | ||
Müller cell changes in human diabetic retinopathy | Q74371192 | ||
Retinal vessel changes in galactose-fed dogs | Q74696564 | ||
Lens and retinal changes in the WBN/Kob rat (spontaneously diabetic strain). Electron-microscopic study | Q74783677 | ||
Retinal hypoxia in long-term diabetic cats | Q77072181 | ||
Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. | Q45926530 | ||
Early lipoic acid intake protects retina of diabetic mice | Q46496432 | ||
The Ins2Akita mouse as a model of early retinal complications in diabetes | Q46508398 | ||
Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice | Q46564923 | ||
Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat. | Q46565438 | ||
Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy. | Q46611983 | ||
AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy | Q46622483 | ||
Early inner retinal dysfunction in streptozotocin-induced diabetic rats | Q46638013 | ||
Electroretinographic study of spontaneously diabetic Torii rats | Q46699203 | ||
Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. | Q46774689 | ||
Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. | Q46774822 | ||
ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes | Q46782071 | ||
Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes | Q46782102 | ||
CR-6 protects glutathione peroxidase activity in experimental diabetes | Q46928558 | ||
Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. | Q47795728 | ||
Elevated glucose concentration changes the content and cellular localization of AMPA receptors in the retina but not in the hippocampus | Q48485776 | ||
Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. | Q48913574 | ||
Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia | Q49107478 | ||
Pharmacological evidence for the presence of functional beta(3)-adrenoceptors in rat retinal blood vessels. | Q39935043 | ||
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. | Q40020452 | ||
Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes | Q40666660 | ||
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation | Q41275103 | ||
Degeneration of retinal ganglion cells in diabetic dogs and mice: relationship to glycemic control and retinal capillary degeneration | Q41506713 | ||
Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation | Q41998096 | ||
Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse | Q42141781 | ||
Effect of puerarin on retinal pigment epithelial cells apoptosis induced partly by peroxynitrite via Fas/FasL pathway | Q42142207 | ||
Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography | Q42177020 | ||
Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy | Q42177617 | ||
Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan | Q42400411 | ||
Ocular structure and function in an aged monkey with spontaneous diabetes mellitus | Q42472911 | ||
TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations | Q42592010 | ||
Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. | Q42703600 | ||
Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment | Q42722726 | ||
Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation | Q42725397 | ||
Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats | Q42733746 | ||
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy | Q42756254 | ||
Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics | Q42824768 | ||
Evaluation of the impact of diabetes on retinal metabolites by NMR spectroscopy. | Q42854405 | ||
Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes | Q42915712 | ||
Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats | Q42960882 | ||
Application of isoproterenol inhibits diabetic-like changes in the rat retina | Q43056643 | ||
ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina | Q43072986 | ||
Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats | Q43076549 | ||
von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish | Q43119674 | ||
Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy | Q43160577 | ||
Retinal heparanase expression in streptozotocin-induced diabetic rats | Q43174398 | ||
The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2) , elucidated by treatment with CTGFsiRNA. | Q43205603 | ||
Diabetic retinopathy and choroidal angiopathy in diabetic rats (WBN/Kob). | Q43246152 | ||
Retinal localization of the glutamate receptor GluR2 and GluR2-regulating proteins in diabetic rats | Q43251567 | ||
Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy | Q43252211 | ||
Altered expression of aquaporins 1 and 4 coincides with neurodegenerative events in retinas of spontaneously diabetic Torii rats. | Q43277606 | ||
Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine | Q43285278 | ||
Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas | Q43442634 | ||
Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit | Q43637135 | ||
Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy | Q43687875 | ||
Reduction of experimental diabetic vascular leakage and pericyte apoptosis in mice by delivery of αA-crystallin with a recombinant adenovirus | Q43746368 | ||
Early retinal damage in experimental diabetes: electroretinographical and morphological observations | Q44036075 | ||
Retinal and choroidal vasculature in rats with spontaneous diabetes type 2 treated with the angiotensin-converting enzyme inhibitor cilazapril: corrosion cast and electron-microscopic study | Q44151639 | ||
Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds | Q44153453 | ||
Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. | Q44286128 | ||
Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina | Q44536369 | ||
Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina | Q44679483 | ||
Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs | Q44684820 | ||
Oscillatory potential analysis and ERGs of normal and diabetic rats | Q44777411 | ||
A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 | ||
Expression of apoptosis markers in the retinas of human subjects with diabetes | Q44995675 | ||
Death of retinal neurons in streptozotocin-induced diabetic mice | Q45028039 | ||
Retinopathy in monkeys with spontaneous type 2 diabetes | Q45158806 | ||
Retinal heat shock protein 25 in early experimental diabetes | Q45242791 | ||
Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability. | Q45362426 | ||
Effects of sulfinpyrazone on retinal damage induced by experimental diabetes mellitus in rabbits | Q77167155 | ||
Rod photoreceptors in infant rats with a history of oxygen exposure | Q77794494 | ||
Vascular architecture of degenerated retina in WBN/Kob rats: corrosion cast and electron microscopic study | Q78040481 | ||
Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus | Q78040840 | ||
Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization | Q79143886 | ||
Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas | Q79786378 | ||
Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs | Q79885693 | ||
Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy | Q80081032 | ||
Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog | Q80183167 | ||
Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes | Q80510725 | ||
Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy | Q82835101 | ||
Characteristics of diabetic retinopathy in SDT rats | Q83008636 | ||
The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children | Q83333485 | ||
Intraocular expression of thymosin β4 in proliferative diabetic retinopathy | Q83438873 | ||
Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954 | Q83522274 | ||
New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography | Q83823286 | ||
Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion | Q84020816 | ||
Diabetic retinopathy | Q84482290 | ||
Wld(S) protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice | Q84523226 | ||
Vasodilation of retinal arterioles induced by activation of BKCa channels is attenuated in diabetic rats | Q84838870 | ||
Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina | Q84916768 | ||
Tacrolimus (FK506) prevents early retinal neovascularization in streptozotocin-induced diabetic mice | Q87405328 | ||
The BB-rat--an authentic model of human diabetic retinopathy | Q93646191 | ||
Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor | Q39554740 | ||
Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy | Q39638361 | ||
Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs | Q39698638 | ||
Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. | Q39711866 | ||
Diabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments | Q39714430 | ||
Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. | Q39727356 | ||
The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity | Q39756440 | ||
Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia | Q39828041 | ||
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy | Q39901974 | ||
Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo | Q39918429 | ||
A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion | Q39929242 | ||
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia | Q27320203 | ||
Breeding of a non-obese, diabetic strain of mice | Q28276534 | ||
Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy | Q28576755 | ||
Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response | Q28577183 | ||
Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats | Q28577524 | ||
Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes | Q28584295 | ||
Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs | Q30010106 | ||
5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy | Q30393975 | ||
Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes | Q30492552 | ||
Subclinical capillary changes in non-proliferative diabetic retinopathy. | Q30514002 | ||
Retinal capillary changes in Otsuka Long-Evans Tokushima fatty rats (spontaneously diabetic strain). Electron-microscopic study | Q30742058 | ||
Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)--possibility of a new experimental model for diabetic retinopathy | Q30886777 | ||
In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats | Q32006453 | ||
Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin. | Q33245457 | ||
Microglial changes occur without neural cell death in diabetic retinopathy | Q33271223 | ||
Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats | Q33283145 | ||
Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization | Q33292156 | ||
Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity | Q33292414 | ||
Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration | Q33294402 | ||
Genetic determinants of hyaloid and retinal vasculature in zebrafish | Q33302704 | ||
Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy | Q33354053 | ||
Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation | Q33360791 | ||
Apolipoprotein A1 is overexpressed in the retina of diabetic patients. | Q33375239 | ||
Animal models of choroidal and retinal neovascularization | Q33582933 | ||
Transcriptomic comparison of the retina in two mouse models of diabetes | Q33631458 | ||
Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model | Q33639461 | ||
Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats | Q33665353 | ||
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes | Q33773287 | ||
Quantitative analysis of pupillary light reflex by real-time autofluorescent imaging in a diabetic mouse model | Q33805646 | ||
Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function | Q33845105 | ||
Pathophysiological characteristics of diabetic ocular complications in spontaneously diabetic torii rat | Q33873906 | ||
Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy | Q33930304 | ||
Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. | Q33930328 | ||
Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice | Q33994233 | ||
Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats | Q34033023 | ||
Ligation of the pterygopalatine and external carotid arteries induces ischemic damage in the murine retina | Q34081271 | ||
Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop | Q34081378 | ||
Microangiopathic retinopathy in experimental diabetic monkeys | Q34165332 | ||
VEGF expression and cell apoptosis in NOD mouse retina | Q34254508 | ||
Characterization of a Mouse Model of Hyperglycemia and Retinal Neovascularization | Q34254645 | ||
Glucose intolerance in teleost fish: fact or fiction? | Q34278111 | ||
The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats | Q34280920 | ||
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 | ||
CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation. | Q34296553 | ||
High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function | Q34355294 | ||
High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. | Q34355326 | ||
Functional characterization of 58-kilodalton inhibitor of protein kinase in protecting against diabetic retinopathy via the endoplasmic reticulum stress pathway. | Q34493861 | ||
Diabetic eNOS-knockout mice develop accelerated retinopathy. | Q34735429 | ||
Ultrastructural features of retinal capillary basement membrane thickening in diabetic swine | Q34898389 | ||
The zebrafish as a tool for understanding the biology of visual disorders | Q35043686 | ||
Protective effects of hydrogen saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model | Q50436532 | ||
Proliferative vitreoretinopathy in the Swine-a new model. | Q50494678 | ||
Glial reactivity, an early feature of diabetic retinopathy. | Q50511477 | ||
Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation. | Q50514993 | ||
Hypoxia-induced retinopathy model in adult zebrafish. | Q50532574 | ||
Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse. | Q50539855 | ||
Microvascular retinopathy in the Zucker diabetic fatty rat. | Q51052202 | ||
Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. | Q51628940 | ||
Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. | Q52483097 | ||
Diabetes impairs the neuroprotective properties of retinal alpha-crystallins. | Q52609718 | ||
Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. | Q53160082 | ||
Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits. | Q53272014 | ||
Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. | Q54330349 | ||
Two isoforms of Flk-1 transcripts in early diabetic rat retinas. | Q54336760 | ||
Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. | Q54337640 | ||
Increased expression of αA-crystallin in human diabetic eye. | Q54369158 | ||
Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin | Q54405122 | ||
Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. | Q54494445 | ||
Generation of trans-arachidonic acid under nitrative stress is associated with upregulation of thromponsdin-1 in diabetic rats. | Q54575585 | ||
Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms | Q57840010 | ||
Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy | Q59464509 | ||
Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy | Q59621017 | ||
Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina | Q61820579 | ||
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | Q62019449 | ||
Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model | Q62066203 | ||
Development of diabetic complications in a new diabetic strain of rat (WBN/Kob) | Q68029509 | ||
Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes | Q35157994 | ||
The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models | Q35180049 | ||
Expression of endoplasmic reticulum stress-related factors in the retinas of diabetic rats | Q35195608 | ||
The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous | Q35247664 | ||
Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy | Q35405149 | ||
Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage | Q35600275 | ||
Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy | Q35661653 | ||
Icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo | Q35719498 | ||
Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy | Q35791559 | ||
TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy | Q35855616 | ||
Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. | Q35891554 | ||
Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice. | Q36015795 | ||
Diabetes diminishes phosphatidic acid in the retina: a putative mediator for reduced mTOR signaling and increased neuronal cell death | Q36338100 | ||
Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy | Q36571714 | ||
A multifocal electroretinogram model predicting the development of diabetic retinopathy | Q36584270 | ||
Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina | Q36646301 | ||
Applying transgenic zebrafish technology to study the retina. | Q36717110 | ||
Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy | Q36717869 | ||
Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice | Q36744052 | ||
A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications | Q36781103 | ||
Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes. | Q36796104 | ||
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina | Q36807663 | ||
Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist | Q37096956 | ||
Type 1 diabetes in the BB rat: a polygenic disease | Q37141760 | ||
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin | Q37384532 | ||
Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy. | Q37418982 | ||
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis | Q37437199 | ||
The parameters of the porcine eyeball | Q37834453 | ||
The diversity of sex steroid action: regulation of metabolism by estrogen signaling | Q37867854 | ||
Digital ocular fundus imaging: a review | Q37939563 | ||
Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes | Q38294227 | ||
Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat. | Q38585336 | ||
Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy | Q38914306 | ||
Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy | Q38937447 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diabetic retinopathy | Q631361 |
animal disease model | Q64732998 | ||
biomedical investigative technique | Q66648976 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 106594 | |
P577 | publication date | 2013-10-27 | |
P1433 | published in | Journal of Diabetes Research | Q26841822 |
P1476 | title | Animal models of diabetic retinopathy: summary and comparison | |
P478 | volume | 2013 |
Q59796439 | A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury |
Q90679887 | Adult Goat Retinal Neuronal Culture: Applications in Modeling Hyperglycemia |
Q39455385 | Animal models of ocular angiogenesis: from development to pathologies |
Q38715502 | Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents |
Q26766504 | Brain and Retinal Pericytes: Origin, Function and Role |
Q40543143 | Broad Infiltration of Macrophages Leads to a Proinflammatory State in Streptozotocin-Induced Hyperglycemic Mice. |
Q42067217 | Can allopurinol improve retinopathy in diabetic rats? Oxidative stress or uric acid; which one is the culprit? |
Q35717962 | Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy |
Q34564352 | Choosing preclinical study models of diabetic retinopathy: key problems for consideration |
Q35974023 | Compromised Wound Healing in Ischemic Type 2 Diabetic Rats |
Q36102156 | Consumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes |
Q92003034 | Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats |
Q42388898 | Development of diabetes-induced acidosis in the rat retina |
Q49724247 | Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System. |
Q26765466 | Diabetic Retinopathy: Animal Models, Therapies, and Perspectives |
Q48169124 | Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes |
Q36281488 | FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice |
Q28546854 | FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy |
Q51746813 | Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice. |
Q41483514 | Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats |
Q91081552 | Human blood vessel organoids as a model of diabetic vasculopathy |
Q47596081 | Hyperglycemia Alters the Protein Levels of Prominin-1 and VEGFA in the Retina of Albino Rats |
Q37538552 | IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling |
Q40377263 | Identification of putative SNPs in progressive retinal atrophy affected Canis lupus familiaris using exome sequencing |
Q51708546 | Inhibition of HIF-1α decreases expression of pro-inflammatory IL-6 and TNF-α in diabetic retinopathy. |
Q41829980 | Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats |
Q41902127 | Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes |
Q41992574 | Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects |
Q57183608 | Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets |
Q36155334 | Multi-Functional OCT Enables Longitudinal Study of Retinal Changes in a VLDLR Knockout Mouse Model |
Q33845094 | NOX2-Induced Activation of Arginase and Diabetes-Induced Retinal Endothelial Cell Senescence |
Q38258984 | Natural product inhibitors of ocular angiogenesis |
Q60647753 | Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy |
Q100633580 | Noninvasive temporal detection of early retinal vascular changes during diabetes |
Q39627126 | Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice |
Q54956368 | Ocular findings in Zucker Diabetic Fatty rats emphasize the key role of neuroglia degeneration in diabetic retinopathy pathophysiology. |
Q50234493 | Ocular lesions in leptin receptor-deficient medaka (Oryzias latipes). |
Q64245243 | Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes |
Q41261736 | Perivascular Progenitor Cells Derived From Human Embryonic Stem Cells Exhibit Functional Characteristics of Pericytes and Improve the Retinal Vasculature in a Rodent Model of Diabetic Retinopathy |
Q58578901 | Prostaglandin E/EP receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes |
Q36051751 | Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic Rats |
Q38828260 | Review: adiponectin in retinopathy. |
Q37729999 | Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. |
Q48623673 | Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy. |
Q48099937 | Study of retinal neurodegeneration and maculopathy in diabetic Meriones shawi: A particular animal model with human-like macula. |
Q49827430 | Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature |
Q89849546 | Targeting long non-coding RNA MALAT1 alleviates retinal neurodegeneration in diabetic mice |
Q48215353 | Temporal diabetes-induced biochemical changes in distinctive layers of mouse retina |
Q55398453 | The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model. |
Q51430597 | The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown. |
Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
Q38719213 | Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice |
Q55327262 | Young Ossabaw Pigs Fed a Western Diet Exhibit Early Signs of Diabetic Retinopathy. |
Q37202605 | Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats |
Search more.